{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:38:25Z","timestamp":1792571905940,"version":"4.5.0"},"reference-count":278,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41569-020-0433-5","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T07:10:46Z","timestamp":1601449846000},"page":"117-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-7611","authenticated-orcid":false,"given":"Csaba","family":"Matyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Hask\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Liaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3266-2477","authenticated-orcid":false,"given":"Eszter","family":"Trojnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-8108","authenticated-orcid":false,"given":"Pal","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"433_CR1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838\u2013851 (2008).","journal-title":"Lancet"},{"key":"433_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.060","author":"AM Moon","year":"2019","unstructured":"Moon, A. M., Singal, A. G. & Tapper, E. B. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.060 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"433_CR3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/hep.30658","volume":"70","author":"A Do","year":"2019","unstructured":"Do, A., Kuszewski, E. J., Langberg, K. A. & Mehal, W. Z. Incorporating weight loss medications into hepatology practice for nonalcoholic steatohepatitis. Hepatology 70, 1443\u20131456 (2019).","journal-title":"Hepatology"},{"key":"433_CR4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin, L. et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J. Hepatol. 69, 718\u2013735 (2018).","journal-title":"J. Hepatol."},{"key":"433_CR5","doi-asserted-by":"crossref","first-page":"k2817","DOI":"10.1136\/bmj.k2817","volume":"362","author":"EB Tapper","year":"2018","unstructured":"Tapper, E. B. & Parikh, N. D. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ 362, k2817 (2018).","journal-title":"BMJ"},{"key":"433_CR6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong, R. J. et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148, 547\u2013555 (2015).","journal-title":"Gastroenterology"},{"key":"433_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5223\/pghn.2019.22.6.501","volume":"22","author":"JS Ko","year":"2019","unstructured":"Ko, J. S. New perspectives in pediatric nonalcoholic fatty liver disease: epidemiology, genetics, diagnosis, and natural history. Pediatr. Gastroenterol. Hepatol. Nutr. 22, 501\u2013510 (2019).","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"433_CR8","unstructured":"World Health Organization. World health statistics 2018: monitoring health for the SDGs, sustainable development goals (WHO, 2018)."},{"key":"433_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","volume":"16","author":"J Gracia-Sancho","year":"2019","unstructured":"Gracia-Sancho, J., Marrone, G. & Fernandez-Iglesias, A. Hepatic microcirculation and mechanisms of portal hypertension. Nat. Rev. Gastroenterol. Hepatol. 16, 221\u2013234 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"433_CR10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/00365521.2015.1021709","volume":"50","author":"S Moller","year":"2015","unstructured":"Moller, S. & Bendtsen, F. Complications of cirrhosis. A 50 years flashback. Scand. J. Gastroenterol. 50, 763\u2013780 (2015).","journal-title":"Scand. J. Gastroenterol."},{"key":"433_CR11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi, M., Moreau, R., Angeli, P., Schnabl, B. & Arroyo, V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J. Hepatol. 63, 1272\u20131284 (2015).","journal-title":"J. Hepatol."},{"key":"433_CR12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.30916","volume":"71","author":"C Matyas","year":"2020","unstructured":"Matyas, C. et al. Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signalling in an experimental model of hepatic cardiomyopathy. Hepatology 71, 1391\u20131284 (2020).","journal-title":"Hepatology"},{"key":"433_CR13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2019.11.027","volume":"152","author":"E Trojnar","year":"2020","unstructured":"Trojnar, E. et al. Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome. Free Radic. Biol. Med. 152, 540\u2013550 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"433_CR14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","volume":"375","author":"EF Wijdicks","year":"2016","unstructured":"Wijdicks, E. F. Hepatic encephalopathy. N. Engl. J. Med. 375, 1660\u20131670 (2016).","journal-title":"N. Engl. J. Med."},{"key":"433_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cpf.12311","volume":"37","author":"S Wiese","year":"2017","unstructured":"Wiese, S., Hove, J. D. & Moller, S. Cardiac imaging in patients with chronic liver disease. Clin. Physiol. Funct. Imaging 37, 347\u2013356 (2017).","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"433_CR16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","volume":"32","author":"HJ Kowalski","year":"1953","unstructured":"Kowalski, H. J. & Abelmann, W. H. The cardiac output at rest in Laennec\u2019s cirrhosis. J. Clin. Invest. 32, 1025\u20131033 (1953).","journal-title":"J. Clin. Invest."},{"key":"433_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","volume":"71","author":"M Izzy","year":"2020","unstructured":"Izzy, M. et al. Redefining cirrhotic cardiomyopathy for the modern era. Hepatology 71, 334\u2013345 (2020).","journal-title":"Hepatology"},{"key":"433_CR18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17474124.2019.1587293","volume":"13","author":"S Moller","year":"2019","unstructured":"Moller, S., Danielsen, K. V., Wiese, S., Hove, J. D. & Bendtsen, F. An update on cirrhotic cardiomyopathy. Expert Rev. Gastroenterol. Hepatol. 13, 497\u2013505 (2019).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"433_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","volume":"11","author":"S Wiese","year":"2014","unstructured":"Wiese, S., Hove, J. D., Bendtsen, F. & Moller, S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat. Rev. Gastroenterol. Hepatol. 11, 177\u2013186 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"433_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","volume":"58","author":"A Nazar","year":"2013","unstructured":"Nazar, A. et al. Left ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J. Hepatol. 58, 51\u201357 (2013).","journal-title":"J. Hepatol."},{"key":"433_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","volume":"56","author":"M Cazzaniga","year":"2007","unstructured":"Cazzaniga, M. et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 56, 869\u2013875 (2007).","journal-title":"Gut"},{"key":"433_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cardfail.2018.10.013","volume":"25","author":"VA Eyvazian","year":"2019","unstructured":"Eyvazian, V. A. et al. Incidence, predictors, and outcomes of new-onset left ventricular systolic dysfunction after orthotopic liver transplantation. J. Card. Fail. 25, 166\u2013172 (2019).","journal-title":"J. Card. Fail."},{"key":"433_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2016.09.009","volume":"66","author":"WJ Shin","year":"2017","unstructured":"Shin, W. J. et al. Effect of ventriculo-arterial coupling on transplant outcomes in cirrhotics: analysis of pressure-volume curve relations. J. Hepatol. 66, 328\u2013337 (2017).","journal-title":"J. Hepatol."},{"key":"433_CR24","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","volume":"58","author":"L Ruiz-del-Arbol","year":"2013","unstructured":"Ruiz-del-Arbol, L. et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine. Hepatology 58, 1732\u20131741 (2013).","journal-title":"Hepatology"},{"key":"433_CR25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jceh.2018.08.008","volume":"9","author":"M Premkumar","year":"2019","unstructured":"Premkumar, M. et al. Left ventricular diastolic dysfunction is associated with renal dysfunction, poor survival and low health related quality of life in cirrhosis. J. Clin. Exp. Hepatol. 9, 324\u2013333 (2019).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"433_CR26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/liv.13870","volume":"38","author":"S Wiese","year":"2018","unstructured":"Wiese, S. et al. Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome. Liver Int. 38, 1614\u20131623 (2018).","journal-title":"Liver Int."},{"key":"433_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3350\/cmh.2018.0034","volume":"24","author":"SK Lee","year":"2018","unstructured":"Lee, S. K., Song, M. J., Kim, S. H. & Ahn, H. J. Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis. Clin. Mol. Hepatol. 24, 409\u2013416 (2018).","journal-title":"Clin. Mol. Hepatol."},{"key":"433_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28890","volume":"65","author":"MS Desai","year":"2017","unstructured":"Desai, M. S. et al. Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology 65, 189\u2013201 (2017).","journal-title":"Hepatology"},{"key":"433_CR29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","volume":"57","author":"A Bortoluzzi","year":"2013","unstructured":"Bortoluzzi, A. et al. Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms. Hepatology 57, 266\u2013276 (2013).","journal-title":"Hepatology"},{"key":"433_CR30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1139\/cjpp-2017-0060","volume":"95","author":"D Jarkovska","year":"2017","unstructured":"Jarkovska, D. et al. Expression of classical mediators in hearts of rats with hepatic dysfunction. Can. J. Physiol. Pharmacol. 95, 1351\u20131359 (2017).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"433_CR31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/gut.52.10.1511","volume":"52","author":"JH Henriksen","year":"2003","unstructured":"Henriksen, J. H. et al. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 52, 1511\u20131517 (2003).","journal-title":"Gut"},{"key":"433_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/lt.22140","volume":"17","author":"E Coss","year":"2011","unstructured":"Coss, E. et al. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 17, 23\u201331 (2011).","journal-title":"Liver Transpl."},{"key":"433_CR33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/lt.22102","volume":"16","author":"KD Watt","year":"2010","unstructured":"Watt, K. D. et al. Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl. 16, 990\u2013998 (2010).","journal-title":"Liver Transpl."},{"key":"433_CR34","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/liv.12428","volume":"34","author":"S Wiese","year":"2014","unstructured":"Wiese, S. et al. Cardiac and proinflammatory markers predict prognosis in cirrhosis. Liver Int. 34, e19\u2013e30 (2014).","journal-title":"Liver Int."},{"key":"433_CR35","doi-asserted-by":"crossref","first-page":"G253","DOI":"10.1152\/ajpgi.00402.2018","volume":"317","author":"S Wiese","year":"2019","unstructured":"Wiese, S. et al. Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imaging. Am. J. Physiol. Gastrointest. Liver Physiol. 317, G253\u2013G263 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"433_CR36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.14309\/ajg.0000000000000462","volume":"115","author":"AN Koshy","year":"2020","unstructured":"Koshy, A. N. et al. Impaired cardiac reserve on dobutamine stress echocardiography predicts the development of hepatorenal syndrome. Am. J. Gastroenterol. 115, 388\u2013397 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"433_CR37","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","volume":"34","author":"S Moller","year":"2013","unstructured":"Moller, S. & Bernardi, M. Interactions of the heart and the liver. Eur. Heart J. 34, 2804\u20132811 (2013).","journal-title":"Eur. Heart J."},{"key":"433_CR38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3109\/00365521.2012.658856","volume":"47","author":"JH Henriksen","year":"2012","unstructured":"Henriksen, J. H., Fuglsang, S. & Bendtsen, F. Arterial pressure profile in patients with cirrhosis: Fourier analysis of arterial pulse in relation to pressure level, stroke volume, and severity of disease: on the reduction of afterload in the hyperdynamic syndrome. Scand. J. Gastroenterol. 47, 580\u2013590 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"433_CR39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00000542-199101000-00026","volume":"74","author":"JL Robotham","year":"1991","unstructured":"Robotham, J. L., Takata, M., Berman, M. & Harasawa, Y. Ejection fraction revisited. Anesthesiology 74, 172\u2013183 (1991).","journal-title":"Anesthesiology"},{"key":"433_CR40","doi-asserted-by":"crossref","first-page":"G313","DOI":"10.1152\/ajpgi.00328.2019","volume":"318","author":"M Israelsen","year":"2020","unstructured":"Israelsen, M. et al. Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomised controlled trial. Am. J. Physiol. Gastrointest. Liver Physiol. 318, G313\u2013G321 (2020).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"433_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28, 1\u201339.e14 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"433_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15171\/jcvtr.2019.22","volume":"11","author":"M Zamirian","year":"2019","unstructured":"Zamirian, M. et al. Reduced myocardial reserve in cirrhotic patients: an evaluation by dobutamine stress speckle tracking and tissue Doppler imaging (TDI) echocardiography. J. Cardiovasc. Thorac. Res. 11, 127\u2013131 (2019).","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"433_CR43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ultrasmedbio.2017.11.013","volume":"44","author":"RC Rimbas","year":"2018","unstructured":"Rimbas, R. C. et al. New definition criteria of myocardial dysfunction in patients with liver cirrhosis: a speckle tracking and tissue doppler imaging study. Ultrasound Med. Biol. 44, 562\u2013574 (2018).","journal-title":"Ultrasound Med. Biol."},{"key":"433_CR44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10741-016-9552-9","volume":"21","author":"S Moller","year":"2016","unstructured":"Moller, S., Wiese, S., Halgreen, H. & Hove, J. D. Diastolic dysfunction in cirrhosis. Heart Fail. Rev. 21, 599\u2013610 (2016).","journal-title":"Heart Fail. Rev."},{"key":"433_CR45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/TP.0b013e31825f0f97","volume":"94","author":"TF Dowsley","year":"2012","unstructured":"Dowsley, T. F. et al. Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation 94, 646\u2013651 (2012).","journal-title":"Transplantation"},{"key":"433_CR46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4291\/wjgp.v9.i1.28","volume":"9","author":"E Tsiompanidis","year":"2018","unstructured":"Tsiompanidis, E. et al. Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity. World J. Gastrointest. Pathophysiol. 9, 28\u201336 (2018).","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"433_CR47","volume":"7","author":"WA Huang","year":"2018","unstructured":"Huang, W. A., Dunipace, E. A., Sorg, J. M. & Vaseghi, M. Liver disease as a predictor of new-onset atrial fibrillation. J. Am. Heart Assoc. 7, e008703 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"433_CR48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.hrtlng.2019.07.002","volume":"49","author":"AC Adejumo","year":"2020","unstructured":"Adejumo, A. C. et al. Predictors, burden and impact of cardiac arrhythmias among patients hospitalized with end-stage liver disease. Heart Lung 49, 73\u201379 (2020).","journal-title":"Heart Lung"},{"key":"433_CR49","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4254\/wjh.v10.i10.761","volume":"10","author":"R Chokesuwattanaskul","year":"2018","unstructured":"Chokesuwattanaskul, R. et al. Liver transplantation and atrial fibrillation: a meta-analysis. World J. Hepatol. 10, 761\u2013771 (2018).","journal-title":"World J. Hepatol."},{"key":"433_CR50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/egh.12.83","volume":"7","author":"A Berzigotti","year":"2013","unstructured":"Berzigotti, A., Seijo, S., Reverter, E. & Bosch, J. Assessing portal hypertension in liver diseases. Expert Rev. Gastroenterol. Hepatol. 7, 141\u2013155 (2013).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"433_CR51","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","volume":"62","author":"J Bosch","year":"2015","unstructured":"Bosch, J., Groszmann, R. J. & Shah, V. H. Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments. J. Hepatol. 62, S121\u2013S130 (2015).","journal-title":"J. Hepatol."},{"key":"433_CR52","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann, R. J. et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N. Engl. J. Med. 353, 2254\u20132261 (2005).","journal-title":"N. Engl. J. Med."},{"key":"433_CR53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","volume":"133","author":"C Ripoll","year":"2007","unstructured":"Ripoll, C. et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133, 481\u2013488 (2007).","journal-title":"Gastroenterology"},{"key":"433_CR54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","volume":"50","author":"C Ripoll","year":"2009","unstructured":"Ripoll, C. et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J. Hepatol. 50, 923\u2013928 (2009).","journal-title":"J. Hepatol."},{"key":"433_CR55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0016-5085(99)70455-5","volume":"117","author":"E Moitinho","year":"1999","unstructured":"Moitinho, E. et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117, 626\u2013631 (1999).","journal-title":"Gastroenterology"},{"key":"433_CR56","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","volume":"131","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico, G., Garcia-Pagan, J. C., Luca, A. & Bosch, J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131, 1611\u20131624 (2006).","journal-title":"Gastroenterology"},{"key":"433_CR57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","volume":"38","author":"S Moller","year":"2018","unstructured":"Moller, S. & Bendtsen, F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 38, 570\u2013580 (2018).","journal-title":"Liver Int."},{"key":"433_CR58","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","volume":"20","author":"M Bolognesi","year":"2014","unstructured":"Bolognesi, M., Di Pascoli, M., Verardo, A. & Gatta, A. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J. Gastroenterol. 20, 2555\u20132563 (2014).","journal-title":"World J. Gastroenterol."},{"key":"433_CR59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00365521.2020.1744709","volume":"55","author":"S Moller","year":"2020","unstructured":"Moller, S., Kimer, N., Barlose, M. & Bendtsen, F. Pathophysiological-based treatments of complications of cirrhosis. Scand. J. Gastroenterol. 55, 383\u2013394 (2020).","journal-title":"Scand. J. Gastroenterol."},{"key":"433_CR60","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","volume":"119","author":"RW Schrier","year":"2006","unstructured":"Schrier, R. W. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am. J. Med. 119, S47\u2013S53 (2006).","journal-title":"Am. J. Med."},{"key":"433_CR61","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/00365520902912555","volume":"44","author":"S Moller","year":"2009","unstructured":"Moller, S., Henriksen, J. H. & Bendtsen, F. Ascites: pathogenesis and therapeutic principles. Scand. J. Gastroenterol. 44, 902\u2013911 (2009).","journal-title":"Scand. J. Gastroenterol."},{"key":"433_CR62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.03.001","volume":"53","author":"European Association for the Study of the Liver.","year":"2010","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 53, 397\u2013417 (2010).","journal-title":"J. Hepatol."},{"key":"433_CR63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","volume":"4","author":"P Gines","year":"2018","unstructured":"Gines, P. et al. Hepatorenal syndrome. Nat. Rev. Dis. Primers 4, 23 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"433_CR64","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","volume":"71","author":"P Angeli","year":"2019","unstructured":"Angeli, P., Garcia-Tsao, G., Nadim, M. K. & Parikh, C. R. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J. Hepatol. 71, 811\u2013822 (2019).","journal-title":"J. Hepatol."},{"key":"433_CR65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","volume":"16","author":"JCQ Velez","year":"2020","unstructured":"Velez, J. C. Q., Therapondos, G. & Juncos, L. A. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nat. Rev. Nephrol. 16, 137\u2013155 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"433_CR66","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/liv.13893","volume":"38","author":"C Sole","year":"2018","unstructured":"Sole, C., Pose, E., Sola, E. & Gines, P. Hepatorenal syndrome in the era of acute kidney injury. Liver Int. 38, 1891\u20131901 (2018).","journal-title":"Liver Int."},{"key":"433_CR67","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","volume":"15","author":"J Puthumana","year":"2017","unstructured":"Puthumana, J. et al. Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 15, 1003\u20131013.e3 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"433_CR68","first-page":"CD013103","volume":"9","author":"LM Best","year":"2019","unstructured":"Best, L. M. et al. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst. Rev. 9, CD013103 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"433_CR69","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","volume":"146","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer, M. et al. Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 146, 1680\u20131690.e1 (2014).","journal-title":"Gastroenterology"},{"key":"433_CR70","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","volume":"100","author":"MJ Krowka","year":"2016","unstructured":"Krowka, M. J. et al. International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 100, 1440\u20131452 (2016).","journal-title":"Transplantation"},{"key":"433_CR71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cld.2019.06.003","volume":"23","author":"R Cartin-Ceba","year":"2019","unstructured":"Cartin-Ceba, R. & Krowka, M. J. Pulmonary complications of portal hypertension. Clin. Liver Dis. 23, 683\u2013711 (2019).","journal-title":"Clin. Liver Dis."},{"key":"433_CR72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2014.01.003","volume":"18","author":"DG Koch","year":"2014","unstructured":"Koch, D. G. & Fallon, M. B. Hepatopulmonary syndrome. Clin. Liver Dis. 18, 407\u2013420 (2014).","journal-title":"Clin. Liver Dis."},{"key":"433_CR73","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ccm.2017.08.002","volume":"38","author":"S Iqbal","year":"2017","unstructured":"Iqbal, S., Smith, K. A. & Khungar, V. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin. Chest Med. 38, 785\u2013795 (2017).","journal-title":"Clin. Chest Med."},{"key":"433_CR74","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0037-1606251","volume":"38","author":"L Savale","year":"2017","unstructured":"Savale, L., Watherald, J. & Sitbon, O. Portopulmonary hypertension. Semin. Respir. Crit. Care Med. 38, 651\u2013661 (2017).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"433_CR75","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","volume":"7","author":"O Sitbon","year":"2019","unstructured":"Sitbon, O. et al. Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respir. Med. 7, 594\u2013604 (2019).","journal-title":"Lancet Respir. Med."},{"key":"433_CR76","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","volume":"8","author":"KL Swanson","year":"2008","unstructured":"Swanson, K. L., Wiesner, R. H., Nyberg, S. L., Rosen, C. B. & Krowka, M. J. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am. J. Transpl. 8, 2445\u20132453 (2008).","journal-title":"Am. J. Transpl."},{"key":"433_CR77","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","volume":"44","author":"MJ Krowka","year":"2006","unstructured":"Krowka, M. J., Swanson, K. L., Frantz, R. P., McGoon, M. D. & Wiesner, R. H. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 44, 1502\u20131510 (2006).","journal-title":"Hepatology"},{"key":"433_CR78","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30197","volume":"69","author":"B AbuHalimeh","year":"2019","unstructured":"AbuHalimeh, B., Krowka, M. J. & Tonelli, A. R. Treatment barriers in portopulmonary hypertension. Hepatology 69, 431\u2013443 (2019).","journal-title":"Hepatology"},{"key":"433_CR79","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jceh.2014.07.006","volume":"5","author":"AR Jayakumar","year":"2015","unstructured":"Jayakumar, A. R., Rama Rao, K. V. & Norenberg, M. D. Neuroinflammation in hepatic encephalopathy: mechanistic aspects. J. Clin. Exp. Hepatol. 5, S21\u2013S28 (2015).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"433_CR80","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jhep.2017.11.005","volume":"68","author":"JS Bajaj","year":"2018","unstructured":"Bajaj, J. S. Hepatic encephalopathy: classification and treatment. J. Hepatol. 68, 838\u2013839 (2018).","journal-title":"J. Hepatol."},{"key":"433_CR81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","volume":"60","author":"J Cordoba","year":"2014","unstructured":"Cordoba, J. et al. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J. Hepatol. 60, 275\u2013281 (2014).","journal-title":"J. Hepatol."},{"key":"433_CR82","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jceh.2018.06.002","volume":"8","author":"PN Bjerring","year":"2018","unstructured":"Bjerring, P. N., Gluud, L. L. & Larsen, F. S. Cerebral blood flow and metabolism in hepatic encephalopathy\u2013a meta-analysis. J. Clin. Exp. Hepatol. 8, 286\u2013293 (2018).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"433_CR83","doi-asserted-by":"publisher","unstructured":"Bajaj, J. S. et al. Minimal hepatic encephalopathy and mild cognitive impairment worsen quality of life in elderly patients with cirrhosis. Clin. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2020.03.033 (2020).","DOI":"10.1016\/j.cgh.2020.03.033"},{"key":"433_CR84","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/hep.30692","volume":"70","author":"S Nardelli","year":"2019","unstructured":"Nardelli, S. et al. Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis. Hepatology 70, 1704\u20131713 (2019).","journal-title":"Hepatology"},{"key":"433_CR85","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/hepr.12873","volume":"47","author":"T Hanai","year":"2017","unstructured":"Hanai, T. et al. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol. Res. 47, 1359\u20131367 (2017).","journal-title":"Hepatol. Res."},{"key":"433_CR86","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup, H. et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60, 715\u2013735 (2014).","journal-title":"Hepatology"},{"key":"433_CR87","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4254\/wjh.v7.i16.1974","volume":"7","author":"M Dirchwolf","year":"2015","unstructured":"Dirchwolf, M. & Ruf, A. E. Role of systemic inflammation in cirrhosis: from pathogenesis to prognosis. World J. Hepatol. 7, 1974\u20131981 (2015).","journal-title":"World J. Hepatol."},{"key":"433_CR88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3350\/cmh.2012.18.4.337","volume":"18","author":"YS Seo","year":"2012","unstructured":"Seo, Y. S. & Shah, V. H. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin. Mol. Hepatol. 18, 337\u2013346 (2012).","journal-title":"Clin. Mol. Hepatol."},{"key":"433_CR89","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.ATV.0000065195.22904.FA","volume":"23","author":"S Chia","year":"2003","unstructured":"Chia, S. et al. Intra-arterial tumor necrosis factor-\u03b1 impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler. Thromb. Vasc. Biol. 23, 695\u2013701 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"433_CR90","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","volume":"293","author":"M Rajesh","year":"2007","unstructured":"Rajesh, M. et al. CB2-receptor stimulation attenuates TNF-\u03b1-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am. J. Physiol. Heart Circ. Physiol. 293, H2210\u2013H2218 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"433_CR91","doi-asserted-by":"crossref","first-page":"G145","DOI":"10.1152\/ajpgi.00097.2011","volume":"302","author":"V Balasubramaniyan","year":"2012","unstructured":"Balasubramaniyan, V. et al. Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G145\u2013G152 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"433_CR92","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI118094","volume":"96","author":"JP Maciejewski","year":"1995","unstructured":"Maciejewski, J. P. et al. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J. Clin. Invest. 96, 1085\u20131092 (1995).","journal-title":"J. Clin. Invest."},{"key":"433_CR93","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1074\/jbc.M006535200","volume":"276","author":"S Bulotta","year":"2001","unstructured":"Bulotta, S., Barsacchi, R., Rotiroti, D., Borgese, N. & Clementi, E. Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-\u03b1. A novel feedback mechanism regulating cell death. J. Biol. Chem. 276, 6529\u20136536 (2001).","journal-title":"J. Biol. Chem."},{"key":"433_CR94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2007-1007110","volume":"19","author":"CJ McClain","year":"1999","unstructured":"McClain, C. J., Barve, S., Deaciuc, I., Kugelmas, M. & Hill, D. Cytokines in alcoholic liver disease. Semin. Liver Dis. 19, 205\u2013219 (1999).","journal-title":"Semin. Liver Dis."},{"key":"433_CR95","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","volume":"112","author":"GL Bird","year":"1990","unstructured":"Bird, G. L., Sheron, N., Goka, A. K., Alexander, G. J. & Williams, R. S. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 112, 917\u2013920 (1990).","journal-title":"Ann. Intern. Med."},{"key":"433_CR96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012).","journal-title":"Nature"},{"key":"433_CR97","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00011-017-1029-3","volume":"66","author":"R Nawaz","year":"2017","unstructured":"Nawaz, R. et al. HCV-induced regulatory alterations of IL-1\u03b2, IL-6, TNF-\u03b1, and IFN- \u03d2 operative, leading liver en-route to non-alcoholic steatohepatitis. Inflamm. Res. 66, 477\u2013486 (2017).","journal-title":"Inflamm. Res."},{"key":"433_CR98","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201008-1303OC","volume":"183","author":"T Thenappan","year":"2011","unstructured":"Thenappan, T. et al. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am. J. Respir. Crit. Care Med. 183, 1080\u20131091 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"433_CR99","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jhep.2012.05.014","volume":"57","author":"J Zhang","year":"2012","unstructured":"Zhang, J. et al. The role of CX(3)CL1\/CX(3)CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J. Hepatol. 57, 752\u2013758 (2012).","journal-title":"J. Hepatol."},{"key":"433_CR100","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1440-1746.2005.03914.x","volume":"20","author":"B Sztrymf","year":"2005","unstructured":"Sztrymf, B. et al. Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome. J. Gastroenterol. Hepatol. 20, 1538\u20131544 (2005).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"433_CR101","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.29915","volume":"68","author":"ZV Varga","year":"2018","unstructured":"Varga, Z. V. et al. Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome in mice. Hepatology 68, 1519\u20131533 (2018).","journal-title":"Hepatology"},{"key":"433_CR102","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","volume":"56","author":"N Shah","year":"2012","unstructured":"Shah, N. et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J. Hepatol. 56, 1047\u20131053 (2012).","journal-title":"J. Hepatol."},{"key":"433_CR103","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s10620-013-2693-y","volume":"58","author":"DS Karagiannakis","year":"2013","unstructured":"Karagiannakis, D. S., Vlachogiannakos, J., Anastasiadis, G., Vafiadis-Zouboulis, I. & Ladas, S. D. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig. Dis. Sci. 58, 3029\u20133036 (2013).","journal-title":"Dig. Dis. Sci."},{"key":"433_CR104","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5085(00)70180-6","volume":"118","author":"H Liu","year":"2000","unstructured":"Liu, H., Ma, Z. & Lee, S. S. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 118, 937\u2013944 (2000).","journal-title":"Gastroenterology"},{"key":"433_CR105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","volume":"53","author":"YY Yang","year":"2010","unstructured":"Yang, Y. Y., Liu, H., Nam, S. W., Kunos, G. & Lee, S. S. Mechanisms of TNF\u03b1-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNF\u03b1 and endocannabinoids. J. Hepatol. 53, 298\u2013306 (2010).","journal-title":"J. Hepatol."},{"key":"433_CR106","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.01.021","volume":"62","author":"SA Gaskari","year":"2015","unstructured":"Gaskari, S. A., Liu, H., D\u2019Mello, C., Kunos, G. & Lee, S. S. Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids. J. Hepatol. 62, 1272\u20131277 (2015).","journal-title":"J. Hepatol."},{"key":"433_CR107","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/039463200702000425","volume":"20","author":"FJ Padillo","year":"2007","unstructured":"Padillo, F. J. et al. Anti-TNF-\u03b1 treatment and bile duct drainage restore cellular immunity and prevent tissue injury in experimental obstructive jaundice. Int. J. Immunopathol. Pharmacol. 20, 855\u2013860 (2007).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"433_CR108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fncel.2016.00167","volume":"10","author":"JM Sheen","year":"2016","unstructured":"Sheen, J. M. et al. Combined intraperitoneal and intrathecal etanercept reduce increased brain tumor necrosis factor-alpha and asymmetric dimethylarginine levels and rescues spatial deficits in young rats after bile duct ligation. Front. Cell Neurosci. 10, 167 (2016).","journal-title":"Front. Cell Neurosci."},{"key":"433_CR109","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","volume":"33","author":"N Shah","year":"2013","unstructured":"Shah, N. et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int. 33, 398\u2013409 (2013).","journal-title":"Liver Int."},{"key":"433_CR110","first-page":"1469","volume":"6","author":"H Yi","year":"2014","unstructured":"Yi, H. et al. The association of lipopolysaccharide and inflammatory factors with hepatopulmonary syndrome and their changes after orthotopic liver transplantation. J. Thorac. Dis. 6, 1469\u20131475 (2014).","journal-title":"J. Thorac. Dis."},{"key":"433_CR111","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/j.gastro.2010.03.040","volume":"139","author":"R Rodrigo","year":"2010","unstructured":"Rodrigo, R. et al. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139, 675\u2013684 (2010).","journal-title":"Gastroenterology"},{"key":"433_CR112","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jceh.2018.08.001","volume":"8","author":"R Ochoa-Sanchez","year":"2018","unstructured":"Ochoa-Sanchez, R. & Rose, C. F. Pathogenesis of hepatic encephalopathy in chronic liver disease. J. Clin. Exp. Hepatol. 8, 262\u2013271 (2018).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"433_CR113","volume":"6","author":"R Rai","year":"2015","unstructured":"Rai, R. et al. Reversal of low-grade cerebral edema after lactulose\/rifaximin therapy in patients with cirrhosis and minimal hepatic encephalopathy. Clin. Transl. Gastroenterol. 6, e111 (2015).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"433_CR114","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/jgh.12160","volume":"28","author":"L Jain","year":"2013","unstructured":"Jain, L. et al. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J. Gastroenterol. Hepatol. 28, 1187\u20131193 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"433_CR115","first-page":"G779","volume":"272","author":"MB Fallon","year":"1997","unstructured":"Fallon, M. B., Abrams, G. A., McGrath, J. W., Hou, Z. & Luo, B. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am. J. Physiol. 272, G779\u2013G784 (1997).","journal-title":"Am. J. Physiol."},{"key":"433_CR116","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.30079","volume":"68","author":"S Raevens","year":"2018","unstructured":"Raevens, S. & Fallon, M. B. Potential clinical targets in hepatopulmonary syndrome: lessons from experimental models. Hepatology 68, 2016\u20132028 (2018).","journal-title":"Hepatology"},{"key":"433_CR117","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0168-8278(97)80023-2","volume":"26","author":"F Oberti","year":"1997","unstructured":"Oberti, F. et al. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation. J. Hepatol. 26, 167\u2013173 (1997).","journal-title":"J. Hepatol."},{"key":"433_CR118","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher, P., Beckman, J. S. & Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315\u2013424 (2007).","journal-title":"Physiol. Rev."},{"key":"433_CR119","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/hep.22166","volume":"47","author":"J Gracia-Sancho","year":"2008","unstructured":"Gracia-Sancho, J. et al. Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability. Hepatology 47, 1248\u20131256 (2008).","journal-title":"Hepatology"},{"key":"433_CR120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0891-5849(01)00680-3","volume":"31","author":"J Vasquez-Vivar","year":"2001","unstructured":"Vasquez-Vivar, J., Whitsett, J., Martasek, P., Hogg, N. & Kalyanaraman, B. Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic. Biol. Med. 31, 975\u2013985 (2001).","journal-title":"Free Radic. Biol. Med."},{"key":"433_CR121","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41569-018-0030-z","volume":"15","author":"Z Ungvari","year":"2018","unstructured":"Ungvari, Z. et al. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat. Rev. Cardiol. 15, 555\u2013565 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"433_CR122","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrd2222","volume":"6","author":"C Szabo","year":"2007","unstructured":"Szabo, C., Ischiropoulos, H. & Radi, R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6, 662\u2013680 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"433_CR123","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.21228","volume":"44","author":"V Matei","year":"2006","unstructured":"Matei, V. et al. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis. Hepatology 44, 44\u201352 (2006).","journal-title":"Hepatology"},{"key":"433_CR124","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0016-5085(03)00909-0","volume":"125","author":"M Morales-Ruiz","year":"2003","unstructured":"Morales-Ruiz, M. et al. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 125, 522\u2013531 (2003).","journal-title":"Gastroenterology"},{"key":"433_CR125","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0016-5085(99)70408-7","volume":"117","author":"V Shah","year":"1999","unstructured":"Shah, V. et al. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 117, 1222\u20131228 (1999).","journal-title":"Gastroenterology"},{"key":"433_CR126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.21080","volume":"43","author":"M Hernandez-Guerra","year":"2006","unstructured":"Hernandez-Guerra, M. et al. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. Hepatology 43, 485\u2013491 (2006).","journal-title":"Hepatology"},{"key":"433_CR127","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/0886022X.2018.1459699","volume":"40","author":"VP Nickovic","year":"2018","unstructured":"Nickovic, V. P. et al. Oxidative stress, NOx\/l-arginine ratio and glutathione\/glutathione S-transferase ratio as predictors of \u2018sterile inflammation\u2019 in patients with alcoholic cirrhosis and hepatorenal syndrome type II. Ren. Fail. 40, 340\u2013349 (2018).","journal-title":"Ren. Fail."},{"key":"433_CR128","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.2169\/internalmedicine.54.4889","volume":"54","author":"M Terao","year":"2015","unstructured":"Terao, M. et al. Serum oxidative\/anti-oxidative stress balance is dysregulated in potentially pulmonary hypertensive patients with liver cirrhosis: a case control study. Intern. Med. 54, 2815\u20132826 (2015).","journal-title":"Intern. Med."},{"key":"433_CR129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1742-7843.2007.00181.x","volume":"102","author":"R Vercelino","year":"2008","unstructured":"Vercelino, R. et al. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic Clin. Pharmacol. Toxicol. 102, 370\u2013376 (2008).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"433_CR130","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3945\/jn.109.105353","volume":"139","author":"J Tieppo","year":"2009","unstructured":"Tieppo, J. et al. Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. J. Nutr. 139, 1339\u20131346 (2009).","journal-title":"J. Nutr."},{"key":"433_CR131","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/ajg.2011.123","volume":"106","author":"C Montoliu","year":"2011","unstructured":"Montoliu, C. et al. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am. J. Gastroenterol. 106, 1629\u20131637 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"433_CR132","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/hep.23656","volume":"52","author":"B Gorg","year":"2010","unstructured":"Gorg, B. et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 52, 256\u2013265 (2010).","journal-title":"Hepatology"},{"key":"433_CR133","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(91)91384-7","volume":"337","author":"P Vallance","year":"1991","unstructured":"Vallance, P. & Moncada, S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 337, 776\u2013778 (1991).","journal-title":"Lancet"},{"key":"433_CR134","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0168-8278(96)80124-3","volume":"25","author":"PA Cahill","year":"1996","unstructured":"Cahill, P. A., Redmond, E. M., Hodges, R., Zhang, S. & Sitzmann, J. V. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J. Hepatol. 25, 370\u2013378 (1996).","journal-title":"J. Hepatol."},{"key":"433_CR135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-8278(97)80012-8","volume":"26","author":"S Battista","year":"1997","unstructured":"Battista, S. et al. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J. Hepatol. 26, 75\u201380 (1997).","journal-title":"J. Hepatol."},{"key":"433_CR136","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/gut.2004.063735","volume":"54","author":"M Bolognesi","year":"2005","unstructured":"Bolognesi, M. et al. Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites. Gut 54, 1630\u20131636 (2005).","journal-title":"Gut"},{"key":"433_CR137","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/hep.510240630","volume":"24","author":"M Morales-Ruiz","year":"1996","unstructured":"Morales-Ruiz, M. et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24, 1481\u20131486 (1996).","journal-title":"Hepatology"},{"key":"433_CR138","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1478-3231.2005.01092.x","volume":"25","author":"P Angeli","year":"2005","unstructured":"Angeli, P. et al. The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites. Liver Int. 25, 429\u2013437 (2005).","journal-title":"Liver Int."},{"key":"433_CR139","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.20151","volume":"39","author":"YC Chen","year":"2004","unstructured":"Chen, Y. C. et al. Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats. Hepatology 39, 1075\u20131087 (2004).","journal-title":"Hepatology"},{"key":"433_CR140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21491","volume":"45","author":"RP Mookerjee","year":"2007","unstructured":"Mookerjee, R. P. et al. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis. Hepatology 45, 62\u201371 (2007).","journal-title":"Hepatology"},{"key":"433_CR141","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.metabol.2010.07.027","volume":"60","author":"T Kasumov","year":"2011","unstructured":"Kasumov, T. et al. Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease. Metabolism 60, 776\u2013781 (2011).","journal-title":"Metabolism"},{"key":"433_CR142","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2362.2007.01814.x","volume":"37","author":"F Vizzutti","year":"2007","unstructured":"Vizzutti, F. et al. ADMA correlates with portal pressure in patients with compensated cirrhosis. Eur. J. Clin. Invest. 37, 509\u2013515 (2007).","journal-title":"Eur. J. Clin. Invest."},{"key":"433_CR143","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.20817","volume":"42","author":"S Fiorucci","year":"2005","unstructured":"Fiorucci, S. et al. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42, 539\u2013548 (2005).","journal-title":"Hepatology"},{"key":"433_CR144","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/SHK.0b013e3182736688","volume":"39","author":"EJ Norris","year":"2013","unstructured":"Norris, E. J., Larion, S., Culberson, C. R. & Clemens, M. G. Hydrogen sulfide differentially affects the hepatic vasculature in response to phenylephrine and endothelin 1 during endotoxemia. Shock 39, 168\u2013175 (2013).","journal-title":"Shock"},{"key":"433_CR145","doi-asserted-by":"crossref","first-page":"H21","DOI":"10.1152\/ajpheart.00577.2016","volume":"312","author":"S Fiorucci","year":"2017","unstructured":"Fiorucci, S., Zampella, A., Cirino, G., Bucci, M. & Distrutti, E. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators. Am. J. Physiol. Heart Circ. Physiol. 312, H21\u2013H32 (2017).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"433_CR146","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4254\/wjh.v7.i3.443","volume":"7","author":"B Vairappan","year":"2015","unstructured":"Vairappan, B. Endothelial dysfunction in cirrhosis: role of inflammation and oxidative stress. World J. Hepatol. 7, 443\u2013459 (2015).","journal-title":"World J. Hepatol."},{"key":"433_CR147","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","volume":"142","author":"G Xie","year":"2012","unstructured":"Xie, G. et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology 142, 918\u2013927.e6 (2012).","journal-title":"Gastroenterology"},{"key":"433_CR148","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","volume":"61","author":"Y Iwakiri","year":"2014","unstructured":"Iwakiri, Y., Shah, V. & Rockey, D. C. Vascular pathobiology in chronic liver disease and cirrhosis \u2013 current status and future directions. J. Hepatol. 61, 912\u2013924 (2014).","journal-title":"J. Hepatol."},{"key":"433_CR149","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson, J. et al. Liver sinusoidal endothelial cells: physiology and role in liver diseases. J. Hepatol. 66, 212\u2013227 (2017).","journal-title":"J. Hepatol."},{"key":"433_CR150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.1840070117","volume":"7","author":"T Horn","year":"1987","unstructured":"Horn, T., Christoffersen, P. & Henriksen, J. H. Alcoholic liver injury: defenestration in noncirrhotic livers\u2013a scanning electron microscopic study. Hepatology 7, 77\u201382 (1987).","journal-title":"Hepatology"},{"key":"433_CR151","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2353\/ajpath.2008.070720","volume":"173","author":"LD DeLeve","year":"2008","unstructured":"DeLeve, L. D., Wang, X., Kanel, G. C., Atkinson, R. D. & McCuskey, R. S. Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am. J. Pathol. 173, 993\u20131001 (2008).","journal-title":"Am. J. Pathol."},{"key":"433_CR152","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.22351","volume":"48","author":"LD Deleve","year":"2008","unstructured":"Deleve, L. D., Wang, X. & Guo, Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology 48, 920\u2013930 (2008).","journal-title":"Hepatology"},{"key":"433_CR153","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","volume":"65","author":"G Marrone","year":"2016","unstructured":"Marrone, G., Shah, V. H. & Gracia-Sancho, J. Sinusoidal communication in liver fibrosis and regeneration. J. Hepatol. 65, 608\u2013617 (2016).","journal-title":"J. Hepatol."},{"key":"433_CR154","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2017.00007","volume":"4","author":"A Fernandez-Iglesias","year":"2017","unstructured":"Fernandez-Iglesias, A. & Gracia-Sancho, J. How to face chronic liver disease: the sinusoidal perspective. Front. Med. 4, 7 (2017).","journal-title":"Front. Med."},{"key":"433_CR155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2003.00880.x","volume":"23","author":"H Yokomori","year":"2003","unstructured":"Yokomori, H. et al. Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells. Liver Int. 23, 467\u2013475 (2003).","journal-title":"Liver Int."},{"key":"433_CR156","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/bbrc.2000.4148","volume":"280","author":"J Funyu","year":"2001","unstructured":"Funyu, J., Mochida, S., Inao, M., Matsui, A. & Fujiwara, K. VEGF can act as vascular permeability factor in the hepatic sinusoids through upregulation of porosity of endothelial cells. Biochem. Biophys. Res. Commun. 280, 481\u2013485 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"433_CR157","volume":"6","author":"D May","year":"2011","unstructured":"May, D. et al. A transgenic model for conditional induction and rescue of portal hypertension reveals a role of VEGF-mediated regulation of sinusoidal fenestrations. PLoS ONE 6, e21478 (2011).","journal-title":"PLoS ONE"},{"key":"433_CR158","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher, P., Batkai, S. & Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389\u2013462 (2006).","journal-title":"Pharmacol. Rev."},{"key":"433_CR159","doi-asserted-by":"crossref","first-page":"H1689","DOI":"10.1152\/ajpheart.00538.2007","volume":"293","author":"S Batkai","year":"2007","unstructured":"Batkai, S. et al. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. Am. J. Physiol. Heart Circ. Physiol. 293, H1689\u2013H1695 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"433_CR160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.108.047035","volume":"74","author":"VL Hegde","year":"2008","unstructured":"Hegde, V. L. et al. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol. Pharmacol. 74, 20\u201333 (2008).","journal-title":"Mol. Pharmacol."},{"key":"433_CR161","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman, D. et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 115, 1298\u20131305 (2005).","journal-title":"J. Clin. Invest."},{"key":"433_CR162","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1478-3231.2006.01401.x","volume":"27","author":"N Mendez-Sanchez","year":"2007","unstructured":"Mendez-Sanchez, N. et al. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease. Liver Int. 27, 215\u2013219 (2007).","journal-title":"Liver Int."},{"key":"433_CR163","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bph.13722","volume":"175","author":"ZV Varga","year":"2018","unstructured":"Varga, Z. V. et al. \u03b2-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice. Br. J. Pharmacol. 175, 320\u2013334 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"433_CR164","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1189\/jlb.0307180","volume":"82","author":"M Rajesh","year":"2007","unstructured":"Rajesh, M. et al. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia\/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J. Leukoc. Biol. 82, 1382\u20131389 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"433_CR165","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1096\/fj.06-7451com","volume":"21","author":"S Batkai","year":"2007","unstructured":"Batkai, S. et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia\/reperfusion injury. FASEB J. 21, 1788\u20131800 (2007).","journal-title":"FASEB J."},{"key":"433_CR166","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gutjnl-2018-316137","volume":"68","author":"A Habib","year":"2019","unstructured":"Habib, A. et al. Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver. Gut 68, 522\u2013532 (2019).","journal-title":"Gut"},{"key":"433_CR167","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","volume":"12","author":"F Teixeira-Clerc","year":"2006","unstructured":"Teixeira-Clerc, F. et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12, 671\u2013676 (2006).","journal-title":"Nat. Med."},{"key":"433_CR168","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.107.131896","volume":"324","author":"J Munoz-Luque","year":"2008","unstructured":"Munoz-Luque, J. et al. Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J. Pharmacol. Exp. Ther. 324, 475\u2013483 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"433_CR169","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","volume":"128","author":"B Julien","year":"2005","unstructured":"Julien, B. et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128, 742\u2013755 (2005).","journal-title":"Gastroenterology"},{"key":"433_CR170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","volume":"36","author":"M Maccarrone","year":"2015","unstructured":"Maccarrone, M. et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol. Sci. 36, 277\u2013296 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"433_CR171","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","volume":"15","author":"P Pacher","year":"2018","unstructured":"Pacher, P., Steffens, S., Hasko, G., Schindler, T. H. & Kunos, G. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat. Rev. Cardiol. 15, 151\u2013166 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"433_CR172","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","volume":"50","author":"P Pacher","year":"2011","unstructured":"Pacher, P. & Mechoulam, R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res. 50, 193\u2013211 (2011).","journal-title":"Prog. Lipid Res."},{"key":"433_CR173","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","volume":"7","author":"S Batkai","year":"2001","unstructured":"Batkai, S. et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med. 7, 827\u2013832 (2001).","journal-title":"Nat. Med."},{"key":"433_CR174","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/sj.bjp.0706928","volume":"149","author":"L Moezi","year":"2006","unstructured":"Moezi, L. et al. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. Br. J. Pharmacol. 149, 898\u2013908 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"433_CR175","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3748\/wjg.v23.i19.3396","volume":"23","author":"ESAC Simoes","year":"2017","unstructured":"Simoes, E. S. A. C., Miranda, A. S., Rocha, N. P. & Teixeira, A. L. Renin angiotensin system in liver diseases: friend or foe? World J. Gastroenterol. 23, 3396\u20133406 (2017).","journal-title":"World J. Gastroenterol."},{"key":"433_CR176","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","volume":"47","author":"CB Herath","year":"2007","unstructured":"Herath, C. B. et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J. Hepatol. 47, 387\u2013395 (2007).","journal-title":"J. Hepatol."},{"key":"433_CR177","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3748\/wjg.15.2512","volume":"15","author":"WW Vilas-Boas","year":"2009","unstructured":"Vilas-Boas, W. W. et al. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis. World J. Gastroenterol. 15, 2512\u20132519 (2009).","journal-title":"World J. Gastroenterol."},{"key":"433_CR178","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20120030","volume":"123","author":"JA Grace","year":"2012","unstructured":"Grace, J. A., Herath, C. B., Mak, K. Y., Burrell, L. M. & Angus, P. W. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options. Clin. Sci. 123, 225\u2013239 (2012).","journal-title":"Clin. Sci."},{"key":"433_CR179","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.510240137","volume":"24","author":"DC Rockey","year":"1996","unstructured":"Rockey, D. C. & Weisiger, R. A. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 24, 233\u2013240 (1996).","journal-title":"Hepatology"},{"key":"433_CR180","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.510290203","volume":"29","author":"AW Schneider","year":"1999","unstructured":"Schneider, A. W., Kalk, J. F. & Klein, C. P. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 29, 334\u2013339 (1999).","journal-title":"Hepatology"},{"key":"433_CR181","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","volume":"125","author":"R Bataller","year":"2003","unstructured":"Bataller, R. et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125, 117\u2013125 (2003).","journal-title":"Gastroenterology"},{"key":"433_CR182","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/gast.2002.36561","volume":"123","author":"G Paizis","year":"2002","unstructured":"Paizis, G. et al. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123, 1667\u20131676 (2002).","journal-title":"Gastroenterology"},{"key":"433_CR183","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","volume":"34","author":"H Yoshiji","year":"2001","unstructured":"Yoshiji, H. et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34, 745\u2013750 (2001).","journal-title":"Hepatology"},{"key":"433_CR184","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L Ruiz-del-Arbol","year":"2005","unstructured":"Ruiz-del-Arbol, L. et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42, 439\u2013447 (2005).","journal-title":"Hepatology"},{"key":"433_CR185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2006.10.018","volume":"46","author":"RM Pereira","year":"2007","unstructured":"Pereira, R. M. et al. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1-7). J. Hepatol. 46, 674\u2013681 (2007).","journal-title":"J. Hepatol."},{"key":"433_CR186","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","volume":"2","author":"S Bansal","year":"2009","unstructured":"Bansal, S., Lindenfeld, J. & Schrier, R. W. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ. Heart Fail. 2, 370\u2013376 (2009).","journal-title":"Circ. Heart Fail."},{"key":"433_CR187","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","volume":"14","author":"J Hartupee","year":"2017","unstructured":"Hartupee, J. & Mann, D. L. Neurohormonal activation in heart failure with reduced ejection fraction. Nat. Rev. Cardiol. 14, 30\u201338 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"433_CR188","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12072-014-9531-y","volume":"8","author":"M Chayanupatkul","year":"2014","unstructured":"Chayanupatkul, M. & Liangpunsakul, S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol. Int. 8, 308\u2013315 (2014).","journal-title":"Hepatol. Int."},{"key":"433_CR189","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12072-008-9100-3","volume":"2","author":"S Moller","year":"2008","unstructured":"Moller, S., Henriksen, J. H. & Bendtsen, F. Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatol. Int. 2, 416\u2013428 (2008).","journal-title":"Hepatol. Int."},{"key":"433_CR190","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/ars.2012.4588","volume":"19","author":"D Zablocki","year":"2013","unstructured":"Zablocki, D. & Sadoshima, J. Angiotensin II and oxidative stress in the failing heart. Antioxid. Redox Signal. 19, 1095\u20131109 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"433_CR191","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411\u2013415 (1988).","journal-title":"Nature"},{"key":"433_CR192","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-8278(05)80584-7","volume":"19","author":"S Moller","year":"1993","unstructured":"Moller, S., Emmeluth, C. & Henriksen, J. H. Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J. Hepatol. 19, 285\u2013290 (1993).","journal-title":"J. Hepatol."},{"key":"433_CR193","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/gast.1996.v110.pm8566602","volume":"110","author":"M Pinzani","year":"1996","unstructured":"Pinzani, M. et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110, 534\u2013548 (1996).","journal-title":"Gastroenterology"},{"key":"433_CR194","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","volume":"327","author":"K Moore","year":"1992","unstructured":"Moore, K. et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N. Engl. J. Med. 327, 1774\u20131778 (1992).","journal-title":"N. Engl. J. Med."},{"key":"433_CR195","doi-asserted-by":"crossref","first-page":"G752","DOI":"10.1152\/ajpgi.00302.2017","volume":"315","author":"CL Chuang","year":"2018","unstructured":"Chuang, C. L. et al. Endotoxemia-enhanced renal vascular reactivity to endothelin-1 in cirrhotic rats. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G752\u2013G761 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"433_CR196","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/jgh.12670","volume":"30","author":"CL Chuang","year":"2015","unstructured":"Chuang, C. L. et al. Lipopolysaccharide enhanced renal vascular response to endothelin-1 through ETA overexpression in portal hypertensive rats. J. Gastroenterol. Hepatol. 30, 199\u2013207 (2015).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"433_CR197","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/rccm.201209-1583CI","volume":"187","author":"JS Fritz","year":"2013","unstructured":"Fritz, J. S., Fallon, M. B. & Kawut, S. M. Pulmonary vascular complications of liver disease. Am. J. Respir. Crit. Care Med. 187, 133\u2013143 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"433_CR198","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/VHRM.S133921","volume":"14","author":"M Correale","year":"2018","unstructured":"Correale, M. et al. Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand? Vasc. Health Risk Manag. 14, 253\u2013264 (2018).","journal-title":"Vasc. Health Risk Manag."},{"key":"433_CR199","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3748\/wjg.v19.i13.2065","volume":"19","author":"QH Du","year":"2013","unstructured":"Du, Q. H. et al. Increased endothelin receptor B and G protein coupled kinase-2 in the mesentery of portal hypertensive rats. World J. Gastroenterol. 19, 2065\u20132072 (2013).","journal-title":"World J. Gastroenterol."},{"key":"433_CR200","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1073\/pnas.1504557112","volume":"112","author":"CK Hathaway","year":"2015","unstructured":"Hathaway, C. K. et al. Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade. Proc. Natl Acad. Sci. USA 112, 5141\u20135146 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"433_CR201","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/FJC.0b013e31813c6cc3","volume":"50","author":"M Iglarz","year":"2007","unstructured":"Iglarz, M. & Clozel, M. Mechanisms of ET-1-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 50, 621\u2013628 (2007).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"433_CR202","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1053\/j.gastro.2009.01.062","volume":"136","author":"S Zhan","year":"2009","unstructured":"Zhan, S., Chan, C. C., Serdar, B. & Rockey, D. C. Fibronectin stimulates endothelin-1 synthesis in rat hepatic myofibroblasts via a Src\/ERK-regulated signaling pathway. Gastroenterology 136, 2345\u20132355.e1-e4 (2009).","journal-title":"Gastroenterology"},{"key":"433_CR203","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2010.12.026","volume":"317","author":"S Zhan","year":"2011","unstructured":"Zhan, S. & Rockey, D. C. Tumor necrosis factor \u03b1 stimulates endothelin-1 synthesis in rat hepatic stellate cells in hepatic wound healing through a novel IKK\/JNK pathway. Exp. Cell Res. 317, 1040\u20131048 (2011).","journal-title":"Exp. Cell Res."},{"key":"433_CR204","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bcp.2009.04.022","volume":"78","author":"CQ Liu","year":"2009","unstructured":"Liu, C. Q. et al. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of rho kinase. Biochem. Pharmacol. 78, 374\u2013381 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"433_CR205","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1582-4934.2012.01563.x","volume":"16","author":"E Rosado","year":"2012","unstructured":"Rosado, E. et al. Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats. J. Cell Mol. Med. 16, 2461\u20132470 (2012).","journal-title":"J. Cell Mol. Med."},{"key":"433_CR206","doi-asserted-by":"crossref","first-page":"G763","DOI":"10.1152\/ajpgi.00300.2004","volume":"288","author":"M Graupera","year":"2005","unstructured":"Graupera, M. et al. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G763\u2013G770 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"433_CR207","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","volume":"46","author":"Y Iwakiri","year":"2007","unstructured":"Iwakiri, Y. & Groszmann, R. J. Vascular endothelial dysfunction in cirrhosis. J. Hepatol. 46, 927\u2013934 (2007).","journal-title":"J. Hepatol."},{"key":"433_CR208","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/jhep.2003.50004","volume":"37","author":"M Graupera","year":"2003","unstructured":"Graupera, M. et al. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 37, 172\u2013181 (2003).","journal-title":"Hepatology"},{"key":"433_CR209","first-page":"530","volume":"17","author":"G Laffi","year":"1997","unstructured":"Laffi, G., La Villa, G., Pinzani, M., Marra, F. & Gentilini, P. Arachidonic acid derivatives and renal function in liver cirrhosis. Semin. Nephrol. 17, 530\u2013548 (1997).","journal-title":"Semin. Nephrol."},{"key":"433_CR210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-8278(86)80154-4","volume":"3","author":"A Rimola","year":"1986","unstructured":"Rimola, A. et al. Urinary excretion of 6-keto-prostaglandin F1\u03b1, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). J. Hepatol. 3, 111\u2013117 (1986).","journal-title":"J. Hepatol."},{"key":"433_CR211","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.510270105","volume":"27","author":"MC Hou","year":"1998","unstructured":"Hou, M. C. et al. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation. Hepatology 27, 20\u201327 (1998).","journal-title":"Hepatology"},{"key":"433_CR212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.lfs.2018.09.051","volume":"212","author":"M Nascimento","year":"2018","unstructured":"Nascimento, M. et al. Hepatic injury induced by thioacetamide causes aortic endothelial dysfunction by a cyclooxygenase-dependent mechanism. Life Sci. 212, 168\u2013175 (2018).","journal-title":"Life Sci."},{"key":"433_CR213","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.mehy.2014.06.001","volume":"83","author":"A Lacout","year":"2014","unstructured":"Lacout, A. et al. Roles of cyclooxygenase 2 and hepatic venous flow in patients with HHT or hepatopulmonary syndrome. Med. Hypotheses 83, 302\u2013305 (2014).","journal-title":"Med. Hypotheses"},{"key":"433_CR214","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.gene.2019.01.009","volume":"692","author":"X Tang","year":"2019","unstructured":"Tang, X. et al. Cyclooxygenase-2 regulates HPS patient serum induced-directional collective HPMVEC migration via PKC\/Rac signaling pathway. Gene 692, 176\u2013184 (2019).","journal-title":"Gene"},{"key":"433_CR215","volume":"12","author":"CC Chang","year":"2017","unstructured":"Chang, C. C. et al. Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats. PLoS ONE 12, e0179809 (2017).","journal-title":"PLoS ONE"},{"key":"433_CR216","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00408-013-9501-5","volume":"191","author":"RL Awdish","year":"2013","unstructured":"Awdish, R. L. & Cajigas, H. R. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center\u2019s experience. Lung 191, 593\u2013600 (2013).","journal-title":"Lung"},{"key":"433_CR217","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0168-8278(97)80458-8","volume":"26","author":"MI Oliver","year":"1997","unstructured":"Oliver, M. I. et al. Autonomic dysfunction in patients with non-alcoholic chronic liver disease. J. Hepatol. 26, 1242\u20131248 (1997).","journal-title":"J. Hepatol."},{"key":"433_CR218","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0041-1345(03)00587-6","volume":"35","author":"J Perez-Pena","year":"2003","unstructured":"Perez-Pena, J. et al. Autonomic neuropathy in end-stage cirrhotic patients and evolution after liver transplantation. Transpl. Proc. 35, 1834\u20131835 (2003).","journal-title":"Transpl. Proc."},{"key":"433_CR219","first-page":"251","volume":"28","author":"B Milovanovic","year":"2009","unstructured":"Milovanovic, B. et al. Autonomic dysfunction in alcoholic cirrhosis and its relation to sudden cardiac death risk predictors. Gen. Physiol. Biophys. 28, 251\u2013261 (2009).","journal-title":"Gen. Physiol. Biophys."},{"key":"433_CR220","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1530-0277.1992.tb00703.x","volume":"16","author":"A Yokoyama","year":"1992","unstructured":"Yokoyama, A. et al. Prolonged QT interval in alcoholic autonomic nervous dysfunction. Alcohol. Clin. Exp. Res. 16, 1090\u20131092 (1992).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"433_CR221","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0168-8278(98)80022-6","volume":"29","author":"JH Henriksen","year":"1998","unstructured":"Henriksen, J. H., Moller, S., Ring-Larsen, H. & Christensen, N. J. The sympathetic nervous system in liver disease. J. Hepatol. 29, 328\u2013341 (1998).","journal-title":"J. Hepatol."},{"key":"433_CR222","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1440-1746.2003.03044.x","volume":"18","author":"A Iga","year":"2003","unstructured":"Iga, A., Nomura, M., Sawada, Y., Ito, S. & Nakaya, Y. Autonomic nervous dysfunction in patients with liver cirrhosis using 123I-metaiodobenzylguanidine myocardial scintigraphy and spectrum analysis of heart-rate variability. J. Gastroenterol. Hepatol. 18, 651\u2013659 (2003).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"433_CR223","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0168-8278(97)80049-9","volume":"26","author":"JF Dillon","year":"1997","unstructured":"Dillon, J. F. et al. The correction of autonomic dysfunction in cirrhosis by captopril. J. Hepatol. 26, 331\u2013335 (1997).","journal-title":"J. Hepatol."},{"key":"433_CR224","first-page":"750","volume":"89","author":"MT Hendrickse","year":"1994","unstructured":"Hendrickse, M. T. & Triger, D. R. Vagal dysfunction and impaired urinary sodium and water excretion in cirrhosis. Am. J. Gastroenterol. 89, 750\u2013757 (1994).","journal-title":"Am. J. Gastroenterol."},{"key":"433_CR225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2004.02112.x","volume":"20","author":"S Moller","year":"2004","unstructured":"Moller, S. & Henriksen, J. H. Review article: pathogenesis and pathophysiology of hepatorenal syndrome\u2013is there scope for prevention? Aliment. Pharmacol. Ther. 20, 31\u201341 (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"433_CR226","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(86)91556-4","volume":"1","author":"AL Gerbes","year":"1986","unstructured":"Gerbes, A. L., Remien, J., Jungst, D., Sauerbruch, T. & Paumgartner, G. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1, 1409\u20131411 (1986).","journal-title":"Lancet"},{"key":"433_CR227","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840120306","volume":"12","author":"SS Lee","year":"1990","unstructured":"Lee, S. S. et al. Desensitization of myocardial \u03b2-adrenergic receptors in cirrhotic rats. Hepatology 12, 481\u2013485 (1990).","journal-title":"Hepatology"},{"key":"433_CR228","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.22533","volume":"48","author":"G Ceolotto","year":"2008","unstructured":"Ceolotto, G. et al. An abnormal gene expression of the \u03b2-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats. Hepatology 48, 1913\u20131923 (2008).","journal-title":"Hepatology"},{"key":"433_CR229","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/liv.13126","volume":"36","author":"C Di Stefano","year":"2016","unstructured":"Di Stefano, C., Milazzo, V., Milan, A., Veglio, F. & Maule, S. The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature. Liver Int. 36, 1081\u20131089 (2016).","journal-title":"Liver Int."},{"key":"433_CR230","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/hep.510250610","volume":"25","author":"DN Jaue","year":"1997","unstructured":"Jaue, D. N., Ma, Z. & Lee, S. S. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy. Hepatology 25, 1361\u20131365 (1997).","journal-title":"Hepatology"},{"key":"433_CR231","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","volume":"53","author":"S Moller","year":"2010","unstructured":"Moller, S. & Henriksen, J. H. Cirrhotic cardiomyopathy. J. Hepatol. 53, 179\u2013190 (2010).","journal-title":"J. Hepatol."},{"key":"433_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.048","author":"E Alvarado Tapias","year":"2020","unstructured":"Alvarado Tapias, E. et al. Short-term hemodynamic effects of \u03b2-blockers influence survival of patients with decompensated cirrhosis. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.048 (2020).","journal-title":"J. Hepatol."},{"key":"433_CR233","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","volume":"130","author":"S Provencher","year":"2006","unstructured":"Provencher, S. et al. Deleterious effects of \u03b2-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology 130, 120\u2013126 (2006).","journal-title":"Gastroenterology"},{"key":"433_CR234","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1136\/gutjnl-2016-311696","volume":"65","author":"A Brito-Azevedo","year":"2016","unstructured":"Brito-Azevedo, A. et al. Propranolol improves endothelial dysfunction in advanced cirrhosis: the \u2018endothelial exhaustion\u2019 hypothesis. Gut 65, 1391\u20131392 (2016).","journal-title":"Gut"},{"key":"433_CR235","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","volume":"64","author":"JA Leithead","year":"2015","unstructured":"Leithead, J. A. et al. Non-selective \u03b2-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut 64, 1111\u20131119 (2015).","journal-title":"Gut"},{"key":"433_CR236","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.arr.2019.02.002","volume":"51","author":"C Morsiani","year":"2019","unstructured":"Morsiani, C. et al. The peculiar aging of human liver: a geroscience perspective within transplant context. Ageing Res. Rev. 51, 24\u201334 (2019).","journal-title":"Ageing Res. Rev."},{"key":"433_CR237","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/hc4601.099487","volume":"104","author":"S Yusuf","year":"2001","unstructured":"Yusuf, S., Reddy, S., Ounpuu, S. & Anand, S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104, 2746\u20132753 (2001).","journal-title":"Circulation"},{"key":"433_CR238","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.30834","volume":"71","author":"AM Papatheodoridi","year":"2020","unstructured":"Papatheodoridi, A. M., Chrysavgis, L., Koutsilieris, M. & Chatzigeorgiou, A. The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis. Hepatology 71, 363\u2013374 (2020).","journal-title":"Hepatology"},{"key":"433_CR239","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jhep.2016.11.004","volume":"66","author":"T Ramirez","year":"2017","unstructured":"Ramirez, T. et al. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression. J. Hepatol. 66, 601\u2013609 (2017).","journal-title":"J. Hepatol."},{"key":"433_CR240","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/acel.12128","volume":"12","author":"F Sheedfar","year":"2013","unstructured":"Sheedfar, F., Di Biase, S., Koonen, D. & Vinciguerra, M. Liver diseases and aging: friends or foes? Aging Cell 12, 950\u2013954 (2013).","journal-title":"Aging Cell"},{"key":"433_CR241","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2018.11.003","volume":"61","author":"MV Lenti","year":"2019","unstructured":"Lenti, M. V. et al. Mortality rate and risk factors for gastrointestinal bleeding in elderly patients. Eur. J. Intern. Med. 61, 54\u201361 (2019).","journal-title":"Eur. J. Intern. Med."},{"key":"433_CR242","doi-asserted-by":"crossref","first-page":"457613","DOI":"10.1155\/2015\/457613","volume":"2015","author":"J Heidemann","year":"2015","unstructured":"Heidemann, J., Bartels, C., Berssenbrugge, C., Schmidt, H. & Meister, T. Hepatorenal syndrome: outcome of response to therapy and predictors of survival. Gastroenterol. Res. Pract. 2015, 457613 (2015).","journal-title":"Gastroenterol. Res. Pract."},{"key":"433_CR243","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/AC.69.3.3027830","volume":"69","author":"S Raevens","year":"2014","unstructured":"Raevens, S. et al. Prevalence and outcome of diastolic dysfunction in liver transplantation recipients. Acta Cardiol. 69, 273\u2013280 (2014).","journal-title":"Acta Cardiol."},{"key":"433_CR244","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","volume":"162","author":"JL Wolff","year":"2002","unstructured":"Wolff, J. L., Starfield, B. & Anderson, G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch. Intern. Med. 162, 2269\u20132276 (2002).","journal-title":"Arch. Intern. Med."},{"key":"433_CR245","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","volume":"15","author":"QM Anstee","year":"2018","unstructured":"Anstee, Q. M., Mantovani, A., Tilg, H. & Targher, G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 15, 425\u2013439 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"433_CR246","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc16-0091","volume":"39","author":"A Mantovani","year":"2016","unstructured":"Mantovani, A. et al. Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour Holter monitoring. Diabetes Care 39, 1416\u20131423 (2016).","journal-title":"Diabetes Care"},{"key":"433_CR247","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrcardio.2015.191","volume":"13","author":"LH Ling","year":"2016","unstructured":"Ling, L. H., Kistler, P. M., Kalman, J. M., Schilling, R. J. & Hunter, R. J. Comorbidity of atrial fibrillation and heart failure. Nat. Rev. Cardiol. 13, 131\u2013147 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"433_CR248","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","volume":"10","author":"KD Watt","year":"2010","unstructured":"Watt, K. D., Pedersen, R. A., Kremers, W. K., Heimbach, J. K. & Charlton, M. R. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am. J. Transpl. 10, 1420\u20131427 (2010).","journal-title":"Am. J. Transpl."},{"key":"433_CR249","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3389\/fimmu.2018.02302","volume":"9","author":"A Ruggieri","year":"2018","unstructured":"Ruggieri, A., Gagliardi, M. C. & Anticoli, S. Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses? Front. Immunol. 9, 2302 (2018).","journal-title":"Front. Immunol."},{"key":"433_CR250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MEG.0b013e32835ab5dc","volume":"25","author":"B Zhang","year":"2013","unstructured":"Zhang, B. & Wu, Z. Y. Estrogen derivatives: novel therapeutic agents for liver cirrhosis and portal hypertension. Eur. J. Gastroenterol. Hepatol. 25, 263\u2013270 (2013).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"433_CR251","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0676.2003.00811.x","volume":"23","author":"I Shimizu","year":"2003","unstructured":"Shimizu, I. Impact of oestrogens on the progression of liver disease. Liver Int. 23, 63\u201369 (2003).","journal-title":"Liver Int."},{"key":"433_CR252","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.lfs.2003.08.004","volume":"74","author":"G Lu","year":"2004","unstructured":"Lu, G. et al. Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats. Life Sci. 74, 897\u2013907 (2004).","journal-title":"Life Sci."},{"key":"433_CR253","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.3748\/wjg.v11.i22.3441","volume":"11","author":"P Lu","year":"2005","unstructured":"Lu, P. et al. Gender differences in hepatic ischemic reperfusion injury in rats are associated with endothelial cell nitric oxide synthase-derived nitric oxide. World J. Gastroenterol. 11, 3441\u20133445 (2005).","journal-title":"World J. Gastroenterol."},{"key":"433_CR254","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0168-8278(01)00023-X","volume":"34","author":"M Sakamoto","year":"2001","unstructured":"Sakamoto, M. et al. Estrogen upregulates nitric oxide synthase expression in cultured rat hepatic sinusoidal endothelial cells. J. Hepatol. 34, 858\u2013864 (2001).","journal-title":"J. Hepatol."},{"key":"433_CR255","doi-asserted-by":"crossref","first-page":"H1569","DOI":"10.1152\/ajpheart.00396.2018","volume":"315","author":"AE Stanhewicz","year":"2018","unstructured":"Stanhewicz, A. E., Wenner, M. M. & Stachenfeld, N. S. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am. J. Physiol. Heart Circ. Physiol. 315, H1569\u2013H1588 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"433_CR256","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/apt.15026","volume":"48","author":"C Engelmann","year":"2018","unstructured":"Engelmann, C. et al. Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death. Aliment. Pharmacol. Ther. 48, 1271\u20131281 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"433_CR257","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4330\/wjc.v9.i4.347","volume":"9","author":"SM Kim","year":"2017","unstructured":"Kim, S. M. et al. QT prolongation is associated with increased mortality in end stage liver disease. World J. Cardiol. 9, 347\u2013354 (2017).","journal-title":"World J. Cardiol."},{"key":"433_CR258","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","volume":"48","author":"SM Kawut","year":"2008","unstructured":"Kawut, S. M. et al. Clinical risk factors for portopulmonary hypertension. Hepatology 48, 196\u2013203 (2008).","journal-title":"Hepatology"},{"key":"433_CR259","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.23009","volume":"50","author":"R Rao","year":"2009","unstructured":"Rao, R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50, 638\u2013644 (2009).","journal-title":"Hepatology"},{"key":"433_CR260","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","volume":"49","author":"L Miele","year":"2009","unstructured":"Miele, L. et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877\u20131887 (2009).","journal-title":"Hepatology"},{"key":"433_CR261","first-page":"11","volume":"82","author":"LM Bigatello","year":"1987","unstructured":"Bigatello, L. M. et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 82, 11\u201315 (1987).","journal-title":"Am. J. Gastroenterol."},{"key":"433_CR262","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8278(95)80424-2","volume":"22","author":"RS Lin","year":"1995","unstructured":"Lin, R. S. et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J. Hepatol. 22, 165\u2013172 (1995).","journal-title":"J. Hepatol."},{"key":"433_CR263","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jhep.2012.01.019","volume":"56","author":"DE Fouts","year":"2012","unstructured":"Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A. & Schnabl, B. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J. Hepatol. 56, 1283\u20131292 (2012).","journal-title":"J. Hepatol."},{"key":"433_CR264","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki, E. et al. TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis. Nat. Med. 13, 1324\u20131332 (2007).","journal-title":"Nat. Med."},{"key":"433_CR265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.510270106","volume":"27","author":"M Bernardi","year":"1998","unstructured":"Bernardi, M. et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 27, 28\u201334 (1998).","journal-title":"Hepatology"},{"key":"433_CR266","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","volume":"72","author":"X Xiang","year":"2020","unstructured":"Xiang, X. et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming of impaired regeneration pathways in mice. J. Hepatol. 72, 736\u2013745 (2020).","journal-title":"J. Hepatol."},{"key":"433_CR267","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.20658","volume":"41","author":"KL Swanson","year":"2005","unstructured":"Swanson, K. L., Wiesner, R. H. & Krowka, M. J. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 41, 1122\u20131129 (2005).","journal-title":"Hepatology"},{"key":"433_CR268","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/lt.500050502","volume":"5","author":"MJ Krowka","year":"1999","unstructured":"Krowka, M. J., Wiseman, G. A., Steers, J. L. & Wiesner, R. H. Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation. Liver Transpl. Surg. 5, 451\u2013453 (1999).","journal-title":"Liver Transpl. Surg."},{"key":"433_CR269","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/hep.26632","volume":"58","author":"S Casey","year":"2013","unstructured":"Casey, S., Schelleman, A. & Angus, P. Recurrence of hepatopulmonary syndrome post-orthotopic liver transplantation in a patient with noncirrhotic portal hypertension. Hepatology 58, 2205\u20132206 (2013).","journal-title":"Hepatology"},{"key":"433_CR270","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","volume":"6","author":"MJ Krowka","year":"2000","unstructured":"Krowka, M. J. et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 6, 443\u2013450 (2000).","journal-title":"Liver Transpl."},{"key":"433_CR271","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.30040","volume":"68","author":"M Izzy","year":"2018","unstructured":"Izzy, M., Oh, J. & Watt, K. D. Cirrhotic cardiomyopathy after transplantation: neither the transient nor innocent bystander. Hepatology 68, 2008\u20132015 (2018).","journal-title":"Hepatology"},{"key":"433_CR272","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10620-013-2955-8","volume":"59","author":"C Mittal","year":"2014","unstructured":"Mittal, C., Qureshi, W., Singla, S., Ahmad, U. & Huang, M. A. Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure. Dig. Dis. Sci. 59, 674\u2013680 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"433_CR273","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/lt.24060","volume":"21","author":"J Bargehr","year":"2015","unstructured":"Bargehr, J. et al. Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl. 21, 314\u2013320 (2015).","journal-title":"Liver Transpl."},{"key":"433_CR274","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jjcc.2015.04.016","volume":"67","author":"EM Zardi","year":"2016","unstructured":"Zardi, E. M. et al. Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase. J. Cardiol. 67, 125\u2013130 (2016).","journal-title":"J. Cardiol."},{"key":"433_CR275","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","volume":"21","author":"F Wong","year":"2015","unstructured":"Wong, F., Leung, W., Al Beshir, M., Marquez, M. & Renner, E. L. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation. Liver Transpl. 21, 300\u2013307 (2015).","journal-title":"Liver Transpl."},{"key":"433_CR276","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4254\/wjh.v11.i9.678","volume":"11","author":"P Carrier","year":"2019","unstructured":"Carrier, P., Debette-Gratien, M., Jacques, J. & Loustaud-Ratti, V. Cirrhotic patients and older people. World J. Hepatol. 11, 663\u2013677 (2019).","journal-title":"World J. Hepatol."},{"key":"433_CR277","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000000090","volume":"98","author":"SR Sharpton","year":"2014","unstructured":"Sharpton, S. R., Feng, S., Hameed, B., Yao, F. & Lai, J. C. Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes. Transplantation 98, 557\u2013562 (2014).","journal-title":"Transplantation"},{"key":"433_CR278","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW Wong","year":"2018","unstructured":"Wong, V. W., Adams, L. A., de Ledinghen, V., Wong, G. L. & Sookoian, S. Noninvasive biomarkers in NAFLD and NASH \u2013 current progress and future promise. Nat. Rev. Gastroenterol. Hepatol. 15, 461\u2013478 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-020-0433-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-020-0433-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-020-0433-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T20:41:04Z","timestamp":1632948064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-020-0433-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":278,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1038\/s41569-020-0433-5","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"11 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}